Kallikrein 11 Antibody

ELISA: Kallikrein 11 Antibody [33470002]

Product Discontinued

Kallikrein 11 Antibody Summary

• Immunogen: This antibody is specific for the Middle Region of the target protein.
• Specificity: This product is specific for Human KLK11.
• Isotype: IgG
• Clonality: Polyclonal
• Host: Rabbit
• Gene: KLK11
• Purity: Immunogen affinity purified

Applications/Dilutions

• Dilutions:
  • ELISA 1:100-1:2000
  • Immunohistochemistry 1:10-1:500
  • Immunohistochemistry-Paraffin 1:10-1:500
• Application Notes: This product is useful in Immunohistochemistry-Paraffin and has been QC tested in ELISA against recombinant protein only.

Reactivity Notes

Human.

Packaging, Storage & Formulations

• Storage: Store at 4C short term. Aliquot and store at -20C long term. Avoid freeze-thaw cycles.
• Buffer: 20mM Potassium Phosphate (pH 7.0) and 0.15M NaCl
• Preservative: No Preservative
• Purity: Immunogen affinity purified

Notes

Manufactured by SDIX's proprietary Genomic Antibody Technology™. GAT FAQs.

Alternate Names for Kallikrein 11 Antibody

• EC 3.4.21
• EC 3.4.21.-
• EC 3.4.21.4
• Hippostasin
• hK11
• Kallikrein 11
• kallikrein-related peptidase 11
• KLK11
• MGC33060
• PRSS20kallikrein-11
• Serine protease 20
• TLSPhippostasin
• Trypsin-like protease

Background

Hippostasin, also known as KLK11, is a kallikrein-like serine protease, which has two alternatively spliced isoforms, brain-type and prostate-type. Hippostasin plays a role in the prostate, including reproductive and/or tumorigenic functions. Elevated serum levels of hK11 were found in 70% of women with ovarian cancer and in 60% of men with prostate cancer. Analysis of the KLK11 biomarker in serum may aid in the diagnosis and monitoring of ovarian and prostatic carcinoma.

Limitations

This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.

Publications for Kallikrein 11 Antibody (33470002)(3)

Publications using 33470002

• Garrison C, Lastwika K, Zhang Y et al. Proteomic Analysis, Immune Dysregulation, and Pathway Interconnections With Obesity J Proteome Res. 2017-01-06 [PMID: 27769113] (MiAr)
  
  Details:
  Analysis is performed on plasma proteomic data to identify how obesity can alter pathways and to highlight the risk factor for disease in subjects with a high body mass index.
• Rho JH, Lampe PD. High-throughput screening for native autoantigen-autoantibody complexes using antibody microarrays J Proteome Res. 2013-05-03 [PMID: 23541305] (MiAr)
  
  Details:
  A novel method using antibody microarrays is used to detect autoantibody-antigen complexes that can potentially be useful for detection and characterization of diseases.
• El Annan J, Jiang G, Wang D et al. Elevated immunoglobulin to tissue KLK11 in patients with Sjogren syndrome. Cornea. 2013-05-01 [PMID: 23086370] (ELISA, Human)

Bioinformatics

• Gene Symbol: KLK11
• Uniprot:
  • Q9UBX7()